- Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action
[作者:Khorana, AA; Streiff, MB; Farge, D; Mandala, M; Debourdeau, P; Cajfinger, F; Marty, M; Falanga, A; Lyman, GH,期刊:Journal of clinical oncology, 页码:4919-4926 , 文章类型: Review,,卷期:2009年27-29]
- Purpose Venous thromboembolism (VTE) is an increasingly frequent complication of cancer and its treatments, and is associated with worsened mortality and morbidity in patients with cancer. Design The Italian Association ...
- Role of Tissue Factor in Cancer
[作者:Kasthuri, RS; Taubman, MB; Mackman, N,期刊:Journal of clinical oncology, 页码:4834-4838 , 文章类型: Review,,卷期:2009年27-29]
- Tissue factor (TF) is a transmembrane glycoprotein that localizes the coagulation serine protease factor VII/VIIa (FVII/VIIa) to the cell surface. The primary function of TF is to activate the clotting cascade. The TF: F...
- Thrombotic Events in Patients With Cancer Receiving Antiangiogenesis Agents
[作者:Zangari, M; Fink, LM; Elice, F; Zhan, FH; Adcock, DM; Tricot, GJ,期刊:Journal of clinical oncology, 页码:4865-4873 , 文章类型: Review,,卷期:2009年27-29]
- Tumor-associated neoangiogenesis has recently become a suitable target for antineoplastic drug development. In this overview, we discuss specific drug-associated hemostatic complications, the already known pathogenetic m...
|